Skip to main content
OpenTrials

Clinical trial condition

Relapsed or Refractory AML and Other Hematologic Malignancies

Explore clinical trials studying Relapsed or Refractory AML and Other Hematologic Malignancies. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Relapsed or Refractory AML and Other Hematologic Malignancies trial results

Recruiting

Phase I Clinical Trial of KK2845 in Patients With Relapsed or Refractory Acute Myeloid Leukemia and Other Hematologic Malignancies.

NCT06812104

Conditions
Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Kameda General Hospital Kamogawa, Chiba, Japan
  • University of Fukui Hospital Yoshida, Fukui, Japan
  • Kurume University Hospital Kurume, Fukuoka, Japan
  • Hokkaido University Hospital Sapporo, Hokkaido, Japan
View all 17 locations
View Trial Details

Related conditions